USANA Health Sciences Reports Preliminary FY2025 Net Sales and Issues Initial FY2026 Net Sales Outlook

USANA Health Sciences, Inc. (NYSE: USNA) announced preliminary consolidated net sales results for fiscal year 2025 and issued its initial net sales outlook for fiscal year 2026 ahead of its presentation at the 28th Annual ICR Conference in Orlando. For FY2025, the company now anticipates total net sales of approximately $925 million, slightly exceeding its previous guidance of about $920 million. Looking forward to fiscal year 2026, USANA provided an initial net sales outlook ranging from $925 million to $1.0 billion. This outlook reflects expected contributions from its core nutritional business, its direct-to-consumer Hiya segment, and its Rise Wellness unit. Specifically, USANA projects net sales from its core nutritional business of $720 million to $765 million, Hiya’s net sales of $140 million to $155 million, and Rise Wellness’s sales of $65 million to $80 million. USANA noted that fiscal 2026 will be a 52-week year, one week shorter than FY2025, which could affect comparisons in net sales. Rise Wellness—comprising the Rise Bar and Protein Pop brands—recorded meaningful year‑over‑year growth in 2025 and is expected to continue expanding in 2026, with operating margins targeted to reach breakeven as the business invests for growth. USANA’s CFO and COO are slated to discuss the company’s strategy and sales outlook during the ICR conference presentation, with a live audio webcast available on USANA’s investor site. The preliminary results and outlook are based on information available as of the release date and will be updated with the company’s full fourth quarter and fiscal 2025 earnings scheduled for release after the market closes on February 17, 2026. #USANA #NetSalesOutlook #Fiscal2026 #HealthSupplements #SlimScan #GrowthStocks #CANSLIM